- Home
- Applications
- usa pennsylvania
- clinical medicine
- inflammatory response
Show results for
Refine by
Clinical Medicine Product Applications Available In In Usa Pennsylvania
5 applications found
Phase 3 study assessing the Efficacy and Safety of Stempeucel® in Patients with Moderate to Severe ARDS due to COVID ...
ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA
MiniTC™ (USA) and Mini-Stem System™ (EU and other countries) have applications in medical aesthetics, plastic and reconstructive surgery, orthopedics and wound healing among ...
ByJointechlabs Inc. based in North Barrington, ILLINOIS (USA)
Our First DCGI Approved Stem Cell Product: Stempeucel® is the FIRST innovative stem cell based biological product to be approved by DCGI (Indian FDA) for manufacturing and marketing for the treatment of Critical Limb Ischemia (CLI). Stempeucel® product has been licensed to Cipla in India. Stempeutics is seeking partnership for further clinical development and commercialization of Stempeucel® for Global ...
ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA
SFA Therapeutics novel immunomodualtor, SFA006 is planned for testing in COVID-19 Patients 4th Quarter 2020. The trial will test the compound’s ability to prevent the onset of Cytokine Storm Syndrome (CSS) and progression to Acute Respiratory Distress Syndrome (ARDS) in COVID-19 positive patients. Patients will be dosed and monitored for symptom progression hospitalization and ...
BySFA Therapeutics, Inc. based in Jenkintown, PENNSYLVANIA (USA)
Deliver the right cells to the patient on time. Maximize Functional Characterization of Your Precious T Cell Samples. The Opto™ Cell Therapy Development workflow accelerates the creation of better therapeutics by performing multiple functional assays across 1,000s of individual T cells in a matter of days. Deeply characterize, profile, and map your T cell populations at the single-cell level to directly link phenotype to gene ...
ByBruker Corporation based in Billerica, MASSACHUSETTS (USA)